Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-05 Purchase | 2022-05-09 4:42 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 100,000 | $13.5 | $1,350,000 | 1,304,016 (Indirect Direct) | View |
| 2021-12-01 Sale | 2021-12-03 6:56 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,833 | $24.68 | $143,934 | 1,204,016 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 7:00 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,833 | $27.82 | $162,289 | 1,209,849 (Direct) | View |
| 2021-10-12 Sale | 2021-10-14 4:48 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,633 | $26.27 | $148,000 | 1,215,682 (Direct) | View |
| 2021-10-08 Sale | 2021-10-12 6:47 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 200 | $25.03 | $5,006 | 1,221,315 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 6:53 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 5,833 | $25.24 | $147,237 | 1,221,515 (Direct) | View |
| 2021-08-11 Sale | 2021-08-12 5:27 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 621 | $25.15 | $15,619 | 1,227,348 (Direct) | View |
| 2021-08-06 Sale | 2021-08-10 4:55 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 3,829 | $25 | $95,725 | 1,227,969 (Direct) | View |
| 2021-08-05 Sale | 2021-08-06 4:16 pm | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 1,383 | $25 | $34,577 | 1,231,798 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-16 Option Award | 2022-07-01 12:31 pm | N/A 2032-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 19,000 | $0 | 19,000 (Direct) | View |
| 2022-06-15 Exercise | 2022-06-17 4:51 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 4,257 | $0 | 1,308,273 (Direct) | View |
| 2021-06-15 Option Award | 2021-06-17 7:19 pm | N/A 2031-06-15 | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director | 24,257 | $0 | 1,257,438 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-20 7:54 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director 10% Owner | 63,185 | $0 | 1,228,924 (Direct) | View |
Ownership | 2020-10-15 8:16 pm | N/A N/A | Tarsus Pharmaceuticals Inc. | TARS | Ackermann Michael Director 10% Owner | 0 | $0 | 1,505,643 (Direct) | View |
| 2020-06-08 Option Award | 2020-06-10 9:12 pm | N/A N/A | Oyster Point Pharma Inc. | OYST | Ackermann Michael Director | 14,805 | $0 | 292,729 (Direct) | View |